278 related articles for article (PubMed ID: 17279300)
1. Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis.
Shen B; Fazio VW; Remzi FH; Bennett AE; Lopez R; Brzezinski A; Oikonomou I; Sherman KK; Lashner BA
Dis Colon Rectum; 2007 Apr; 50(4):498-508. PubMed ID: 17279300
[TBL] [Abstract][Full Text] [Related]
2. Oral budesonide in the treatment of chronic refractory pouchitis.
Gionchetti P; Rizzello F; Poggioli G; Pierangeli F; Laureti S; Morselli C; Tambasco R; Calabrese C; Campieri M
Aliment Pharmacol Ther; 2007 May; 25(10):1231-6. PubMed ID: 17451569
[TBL] [Abstract][Full Text] [Related]
3. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice.
Shen B; Brzezinski A; Fazio VW; Remzi FH; Achkar JP; Bennett AE; Sherman K; Lashner BA
Aliment Pharmacol Ther; 2005 Oct; 22(8):721-8. PubMed ID: 16197493
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and tolerability of AST-120 (spherical carbon adsorbent) in active pouchitis.
Shen B; Pardi DS; Bennett AE; Queener E; Kammer P; Hammel JP; LaPlaca C; Harris MS
Am J Gastroenterol; 2009 Jun; 104(6):1468-74. PubMed ID: 19436282
[TBL] [Abstract][Full Text] [Related]
5. High-dose probiotics for the treatment of active pouchitis.
Gionchetti P; Rizzello F; Morselli C; Poggioli G; Tambasco R; Calabrese C; Brigidi P; Vitali B; Straforini G; Campieri M
Dis Colon Rectum; 2007 Dec; 50(12):2075-82; discussion 2082-4. PubMed ID: 17934776
[TBL] [Abstract][Full Text] [Related]
6. Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
Gosselink MP; Schouten WR; van Lieshout LM; Hop WC; Laman JD; Ruseler-van Embden JG
Dis Colon Rectum; 2004 Sep; 47(9):1519-25. PubMed ID: 15486751
[TBL] [Abstract][Full Text] [Related]
7. Rifaximin-ciprofloxacin combination therapy is effective in chronic active refractory pouchitis.
Abdelrazeq AS; Kelly SM; Lund JN; Leveson SH
Colorectal Dis; 2005 Mar; 7(2):182-6. PubMed ID: 15720360
[TBL] [Abstract][Full Text] [Related]
8. Association between fecal hydrogen sulfide production and pouchitis.
Ohge H; Furne JK; Springfield J; Rothenberger DA; Madoff RD; Levitt MD
Dis Colon Rectum; 2005 Mar; 48(3):469-75. PubMed ID: 15747080
[TBL] [Abstract][Full Text] [Related]
9. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis.
Mimura T; Rizzello F; Helwig U; Poggioli G; Schreiber S; Talbot IC; Nicholls RJ; Gionchetti P; Campieri M; Kamm MA
Aliment Pharmacol Ther; 2002 May; 16(5):909-17. PubMed ID: 11966499
[TBL] [Abstract][Full Text] [Related]
10. Topical tacrolimus therapy for antibiotic-refractory pouchitis.
Uchino M; Ikeuchi H; Matsuoka H; Bando T; Hida N; Nakamura S; Takesue Y; Tomita N
Dis Colon Rectum; 2013 Oct; 56(10):1166-73. PubMed ID: 24022534
[TBL] [Abstract][Full Text] [Related]
11. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F
Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903
[TBL] [Abstract][Full Text] [Related]
12. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis.
Safdi M; DeMicco M; Sninsky C; Banks P; Wruble L; Deren J; Koval G; Nichols T; Targan S; Fleishman C; Wiita B
Am J Gastroenterol; 1997 Oct; 92(10):1867-71. PubMed ID: 9382054
[TBL] [Abstract][Full Text] [Related]
13. The long-term clinical course of pouchitis after total proctocolectomy and IPAA for ulcerative colitis.
Suzuki H; Ogawa H; Shibata C; Haneda S; Watanabe K; Takahashi K; Funayama Y; Sasaki I
Dis Colon Rectum; 2012 Mar; 55(3):330-6. PubMed ID: 22469801
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses.
Shen B; Fazio VW; Remzi FH; Delaney CP; Bennett AE; Achkar JP; Brzezinski A; Khandwala F; Liu W; Bambrick ML; Bast J; Lashner B
Am J Gastroenterol; 2005 Jan; 100(1):93-101. PubMed ID: 15654787
[TBL] [Abstract][Full Text] [Related]
15. Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis.
Calabrese C; Fabbri A; Gionchetti P; Rizzello F; Morselli C; Liguori G; Poggioli G; Campieri M; Di Febo G
Aliment Pharmacol Ther; 2007 Jun; 25(11):1311-6. PubMed ID: 17509099
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease].
Münster M; Hörauf A; Bilzer T
Berl Munch Tierarztl Wochenschr; 2006; 119(11-12):493-505. PubMed ID: 17172138
[TBL] [Abstract][Full Text] [Related]
17. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
Shen B; Achkar JP; Lashner BA; Ormsby AH; Remzi FH; Brzezinski A; Bevins CL; Bambrick ML; Seidner DL; Fazio VW
Inflamm Bowel Dis; 2001 Nov; 7(4):301-5. PubMed ID: 11720319
[TBL] [Abstract][Full Text] [Related]
18. A cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal pouch-anal anastomosis.
Shen B; Shermock KM; Fazio VW; Achkar JP; Brzezinski A; Bevins CL; Bambrick ML; Remzi FH; Lashner BA
Am J Gastroenterol; 2003 Nov; 98(11):2460-7. PubMed ID: 14638349
[TBL] [Abstract][Full Text] [Related]
19. Pros and cons of antibiotic therapy for pouchitis.
Navaneethan U; Shen B
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):547-59. PubMed ID: 19817675
[TBL] [Abstract][Full Text] [Related]
20. Collagenous pouchitis.
Shen B; Bennett AE; Fazio VW; Sherman KK; Sun J; Remzi FH; Lashner BA
Dig Liver Dis; 2006 Sep; 38(9):704-9. PubMed ID: 16807149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
